Bilcare ushers into successful execution of nonClonableID(TM) technology worldwide
Dr. Sam Pitroda releases technology embedded products across various sectors
Bilcare Technologies, a division of Bilcare Ltd Â BSE: BI, (CODE: 526853)
Â focused on creating next-generation anti-counterfeiting, security and brand
protection solutions, announced successful execution of its nonClonableID(TM)
for the Security, Pharma and Agrochemical sectors with the symbolic hand over of
technology embedded products to leading companies in US and India.
Mr. Mohan Bhandari, Founder, Chairman & Managing Director, Bilcare Limited
announced : "We are working to implement this technology forÂ Delhi Police
Force. It is also being deployed in leading pharmaceutical and agrochemical
companies in India.Â Internationally, this technology has been accepted by a
leading wine producer in USA and for the presidential security of an Asian
country. Bilcare is about to close a deal with a European consumer product
company. On the document security front, a major trial is underway with a
printer manufacturer in USA". Â Mr. Bhandari further added: "I feel excited about
the potential of this great innovation and firmly believe that we finally have a
weapon to fight the challenges of counterfeit menace and give brand owners the
Â security they need, which will not only enhance their sales and profit margins
but will also provide consumers the peace of mind ".
Early in the month , US based company ,Applied DNA Sciences and Bilcare
Technologies signed an agreement to provide a new blended security system
enabling real time, portable authentication along with forensic securitization,
which has already started resulting into business wins.
Worldwide counterfeit market is estimated around 500Bn USD, which adversely
affects the global citizens in many ways.Â Bilcare sees its technology as the
answer to this global problem. To accomplish this, Bilcare has already started
executing projects. The technology is already being used by one of the largest
auto component manufacturer in the world and by museums for security of precious
art and heritage artifacts. Bilcare is continuously working with its customers
to make sure that they get most advanced and customized relevant solutions,
which are scalable and cost effective.
The need to address many vexing challenges like tracking and tracing products,
enhancing supply chain efficiency and traceability, thwarting grey markets and
managing product recalls for instilling confidence in customers are becoming
increasingly important. Bilcare's nonClonableID solution promises to enhance the
value for the customer by effectively addressing these needs says Himanshu
Bhatt, Global Sales Director for Physical Meets Digital Software Solutions Sales
for IBM based in Texas, USA. Â Â Mr. Himanshu stated that IBM and Bilcare are
opportunistically pursuing prospects in the market place to allow customers
derive the value from IBM's established leadership in Smart planet solutions
that combines IBM's Product Traceability software solutions with Bilcare
Dr. Satya Sharma , Global President , Bilcare Technologies, based at US,Â said :
"Most existing anti-counterfeiting technologies have limitations. Being generic
in nature, the counterfeiters are able to figure them out within 9-12 months
after deployment of these technologies by the brand owners.Â However, Bilcare's
nonClonableID(TM) fingerprints are not possible to be copied as even Bilcare
cannot duplicate these fingerprints". Â The unique ability of nonClonableID(TM)
to enable convincing product authentication on a real-time, anytime-anywhere
basis along with complete securitization of the supply chain Â is making it
applicable across diverse sectors viz. pharmaceuticals, agrochemicals,
automotive, financial and document securitization, fashion & luxury goods, art &
heritage and beyond.
About Bilcare Technologies:
Bilcare Technologies is a business unit of Bilcare Ltd. - an innovation-led
solutions provider that partners with the global pharmaceutical and healthcare
industry to improve patient healthcare outcomes. With breakthrough research and
development in micro and nanotechnology, Bilcare Technologies has developed a
first-of-its-kind technology - nonClonableID(TM). The solution enables products
to be authenticated as they move through the supply chain to the end consumer.
Bilcare Technologies has manufacturing facilities in Singapore and India and
application support centers in the UK, Italy and US. It also leverages on the
global network of the Bilcare group to provide sales, marketing and
implementation support throughout the world.Â Bilcare is firmly committed to
helping its clients accomplish their business goals, whilst protecting their
brands against counterfeiting.
Contact Details :
Dr. Satya Sharma
Global President , Bilcare Technologies
Ph : 6313719441
Head, Corporate Communications at Bilcare Ltd.
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
All reproduction for further distribution is prohibited.
Source: Bilcare Global Clinical Supplies via Thomson Reuters ONE